相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of OCT4 in cancer stem-like cells and chemotherapy resistance
Ismail S. Mohiuddin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2020)
MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastoma
Sung-Jen Wei et al.
CELL DEATH & DISEASE (2020)
DNA-PK as an Emerging Therapeutic Target in Cancer
Ismail S. Mohiuddin et al.
FRONTIERS IN ONCOLOGY (2019)
A Fluorescence-Based High-Throughput Assay for the Identification of Anticancer Reagents Targeting Fructose-1,6-Bisphosphate Aldolase
Eun Jeong Cho et al.
SLAS DISCOVERY (2018)
Kinase-targeted cancer therapies: progress, challenges and future directions
Khushwant S. Bhullar et al.
MOLECULAR CANCER (2018)
New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome
Leah J. Wilson et al.
CANCER RESEARCH (2018)
Randomized phase 2 study of investigational aurora A kinase (AAK) inhibitor alisertib (MLN8237) + paclitaxel (P) vs placebo + P as second line therapy for small-cell lung cancer (SCLC)
T.K. Owonikoko et al.
ANNALS OF ONCOLOGY (2017)
Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector
Ziqing Liu et al.
SCIENTIFIC REPORTS (2017)
Drugging the 'undruggable' cancer targets
Chi V. Dang et al.
NATURE REVIEWS CANCER (2017)
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
Gurkan Mollaoglu et al.
CANCER CELL (2017)
Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials
Mario Fiore et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction A Randomized Clinical Trial
Michelle L. O'Donoghue et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: A multicenter FDG-PET trial
Hamed Emami et al.
ATHEROSCLEROSIS (2015)
Targeting cancer with kinase inhibitors
Stefan Gross et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
6 Small Molecule Substrate Phosphorylation Site Inhibitors of Protein Kinases: Approaches and Challenges
Meghan E. Breen et al.
ACS CHEMICAL BIOLOGY (2015)
Acquired resistance to TKIs in solid tumours: learning from lung cancer
D. Ross Camidge et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
MYC Degradation
Amy S. Farrell et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
DSSylation, a novel protein modification targets proteins induced by oxidative stress, and facilitates their degradation in cells
Yinghao Zhang et al.
PROTEIN & CELL (2014)
MYC Acts via the PTEN Tumor Suppressor to Elicit Autoregulation and Genome-Wide Gene Repression by Activation of the Ezh2 Methyltransferase
Mandeep Kaur et al.
CANCER RESEARCH (2013)
SnapShot: p38 MAPK Signaling
Natalia Trempolec et al.
CELL (2013)
The epigenetics of epithelial-mesenchymal plasticity in cancer
Wai Leong Tam et al.
NATURE MEDICINE (2013)
Bypass Mechanisms of Resistance to Receptor Tyrosine Kinase Inhibition in Lung Cancer
Matthew J. Niederst et al.
SCIENCE SIGNALING (2013)
MYC, Metabolism, Cell Growth, and Tumorigenesis
Chi V. Dang
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
c-Myc and Cancer Metabolism
Donald M. Miller et al.
CLINICAL CANCER RESEARCH (2012)
An Integrated Genomic Approach to Identify Predictive Biomarkers of Response to the Aurora Kinase Inhibitor PF-03814735
Kenneth E. Hook et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Synergistic activity of rapamycin and dexamethasone in vitro and in vivo in acute lymphoblastic leukemia via cell-cycle arrest and apoptosis
Chong Zhang et al.
LEUKEMIA RESEARCH (2012)
A framework for identification of actionable cancer genome dependencies in small cell lung cancer
Martin L. Sos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
National Cancer Institute Pediatric Preclinical Testing Program: Model Description for In Vitro Cytotoxicity Testing
Min H. Kang et al.
PEDIATRIC BLOOD & CANCER (2011)
Targeting cancer with small molecule kinase inhibitors
Jianming Zhang et al.
NATURE REVIEWS CANCER (2009)
Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo
Min H. Kang et al.
BLOOD (2007)
Identification of inhibitors of the kinase activity of oncogenic V600EBRAF in an enzyme cascade high-throughput screen
Y Newbatt et al.
JOURNAL OF BIOMOLECULAR SCREENING (2006)
Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification
YH Kim et al.
ONCOGENE (2006)
Screening for cell migration inhibitors via automated microscopy reveals a rho-kinase inhibitor
JC Yarrow et al.
CHEMISTRY & BIOLOGY (2005)
Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis
CM Eischen et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
分享论文
